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Abstract 
Noninvasive molecular imaging using reporter genes is a relatively recent field in biomedical 
imaging that holds great promises for disease diagnosis and therapy. As modern medicine is 
moving  towards  personalized  medicine,  targeted  biomolecule  based  therapies  is  gaining 
popularity that requires careful and systematic validation. Reporter genes have emerged as 
important generalizable tools to overcome the shortcomings of direct evaluation of individual 
biomolecules and are being applied in various fields such as cell therapy, stem cell therapy, 
immune therapy, viral gene delivery through optical, radionuclide, magnetic resonance imaging 
techniques. New approaches to image protein-protein interaction, protein phosphorylation, 
protein folding that are crucial parameters for theranostic study using reporter genes are 
being developed. All these new technologies and relevant preclinical and clinical researches 
will determine the success of early detection and personalized therapy in the future. 
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Amalgamation  of  therapy  with  diagnosis  is  a 
prime  requirement  in  successful  translation  of  re-
search  information  from  bench  to  bedside. 
‘Theranostics’,  a  newly  developed  concept  in  bio-
medical  science,  is  thus  gaining  popularity  in 
pre-clinical  and  clinical  research.  The  science  of 
theranostics  involves  development  of  new  probes, 
new delivery vectors/chemicals and new strategies of 
imaging in cellular and animal models. The goal of 
theranostics is to achieve personalized medicine with 
stratified patient population [1]. At preclinical stage, 
various  reporter  genes  suitable  for  in  vivo  imaging 
using  multiple  modalities  have  become  extremely 
useful  tools  for  theranostic  study.  These  imaging 
strategies based on genetic reporters have contributed 
immensely in developing  better therapeutic and di-
agnostic  procedures  for  disease  evaluation.  In  this 
special  edition,  global  experts  on  reporter  gene  im-
aging  explore  the  potential  use  of  various  reporter 
genes in expanding research areas covering stem cell 
and  immune  cell  mediated  cell  therapy  and  viral 
therapy applications using nuclear medicine imaging 
to  MR  imaging  to  optical  imaging  and  activatable 
imaging strategy. 
Various  cell  based  strategies  have  been  devel-
oped  for  delivering  therapeutic  dose  to  the  disease 
targets.  Cell  therapy  overcomes  many  deleterious 
effects of conventional drug therapy but requires de-
tail  validation  and  ethical  clearance  before  use  in 
human subjects. Recently stem cells are widely used 
for therapy due to their unprecedented power of re-
generating  normal  tissues  which  is  not  possible  by 
other therapeutic approaches. Gu et al. [2] elaborated 
the application of stem cells and induced pluripotent 
stem cells (iPSCs) in monitoring tumorigenicity, im-
munogenicity,  biodistribution  and  how  molecular 
imaging plays roles in answering the crucial questions 
about their clinical applications. Amongst all the ex-
isting imaging methods bioluminescence imaging is 
the most sensitive technique in small animal models 
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due to the high signal to noise ratio. Thus by exploit-
ing the power of optical reporter gene based imaging 
strategy, Huang et al. [3] described the application of 
pluripotent  /adult  /embryonic  stem  cells  to  rectify 
various peripheral vascular disorders.  
Modulating immune system for better treatment 
is a challenge and a constant focus for development of 
personalized medicine, particularly in cancer. In order 
to fully understand the efficacy of immune therapies, 
it is critical to understand how the treatment modu-
lates  the  function  of  each  cell  type  involved  in  the 
anti-cancer  immune  response.  The  development  of 
reporter genes for tracking cell movement and func-
tion  is  a  powerful  addition  to  the  immunologist’s 
toolbox. In a concise review, Dubey [4] elaborated the 
importance  of  non-invasive  imaging  of  innate  and 
adaptive immune cells for their interaction, traffick-
ing,  location  and  functional  analysis  of  immune 
therapy.  
Successful delivery of gene of interest is crucial 
for any therapy and viral vectors have long been used 
for gene therapy. The  safety, non-specific  targeting, 
and efficiency are the major points of improvement 
for these vehicles. In this  issue,  Rojas & Thorne [5] 
described the therapeutic potential of a special group 
of virus, the oncolytic virus that selectively replicate 
in tumor cells. Some of these viruses are already in 
clinical trials and are expected soon to be approved as 
agents  for  cancer  treatment  in  North  America  and 
Europe. 
Though  bioluminescence  imaging  confers  the 
greatest sensitivity amongst all the imaging modali-
ties, it still lacks the power of clinical application. Ra-
dionuclide  imaging,  particularly  the  positron  emis-
sion tomography (PET) reporter genes and reporter 
probes emerge as the most valuable and reliable tools 
for gene and cell therapy from small animal models to 
humans. The advantages of PET reporter gene/probe 
combination  in  theranostics  have  been  discussed  in 
two articles by Yaghoubi et al. [6] and by Ahn B. [7]. 
Yaghoubi et al. comprehensively reviewed the exist-
ing PET reporter genes and the reporter probes for 
preclinical  and  clinical  purposes.  This  review  also 
detailed how academia and industry partnership can 
join hands and set the  stage for evaluation  of gene 
therapy or cell therapy trials. Ahn in his article em-
phasized the diagnostic and therapeutic use of sodi-
um iodide symporter (NIS) and its evolution as a re-
porter  gene.  NIS  gene  mediated  molecular  imaging 
and  radionuclide  gene  therapy  is  one  of  the  most 
promising  examples  of  the  few  theranostic  genes 
discovered to date.  
The  spatio-temporal  imaging  of  genomic  and 
proteomic events in living subjects is the crux of mo-
lecular imaging with reporter genes. Of all the imag-
ing modalities available magnetic resonance imaging 
produces best  spatial resolution and generates both 
functional and anatomical information. Lee et al. [8] 
described  the  principle  of  MRI  and  the  merits  and 
demerits of the four existing MR reporter-based im-
aging approaches.  
In another article, Niu and Chen  [9] described 
the mechanistic approaches of various reporter genes 
with  a  special  emphasis  on  developing  activatable 
sensors to image translational molecular events such 
as protein-protein interactions, protein phosphoryla-
tion or protein folding. Development of such smart 
sensor based imaging approach is an important area 
in molecular imaging that has the propensity to image 
systems biology. 
All together this special issue presents a broad 
spectrum of evidences on how reporter gene imaging 
plays vital roles in diagnosis and therapy. Advance-
ment in theranostic science will allow moving from 
generalized medicine towards personalized medicine 
and early detection of diseases. The success and true 
potential of theranostics is yet to achieve in the clinical 
world. Advanced molecular imaging techniques with 
a  generalized  reporter  gene  platform  would  surely 
assist to determine the path. 
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